Investment Trusts

BioPharma Credit PLC

BPCR:LSE

BioPharma Credit PLC

  • Price (USD)0.926
  • Today's Change0.006 / 0.65%
  • Shares traded230.38k
  • 1 Year change9.72%
  • Beta0.2245
Data delayed at least 20 minutes, as of Feb 06 2026 15:40 GMT.
More ▼
Total returns on $1000
1Y
Fund/benchmarkChange
PriceBioPharma Credit PLC (Ordinary Share)+17.75%
NAVBioPharma Credit PLC (Ordinary Share)+7.25%
Morningstar's BenchmarkNo benchmark--

Key statistics

On Friday, BioPharma Credit PLC (BPCR:LSE) closed at 0.926, -5.49% below its 52-week high of 0.9798, set on Jun 30, 2025.
52-week range
Today
0.80Apr 09 20250.9798Jun 30 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding1.13bn
Market cap1.04bn USD
Total assets1.16bn USD
Total expense ratio--
High0.928
Low0.92
Previous close0.92
Average volume876.80k
YTD Change+1.09%
Beta0.2245
Diluted NAV (est)1.03
Diluted NAV (last pub)1.02
Premium/Discount-9.59%
Net Gearing0.00%
Annual div (ADY)0.070 USD
Annual div yield (ADY)7.61%
Div ex-dateSep 25 2025
Div pay-dateOct 31 2025
Data delayed at least 20 minutes, as of Feb 06 2026 15:40 GMT.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.